Mechanism of malarial haem detoxification inhibition by chloroquine.

The haem detoxification pathway of the malaria parasite Plasmodium falciparum is a potential biochemical target for drug development. Free haem, released after haemoglobin degradation, is polymerized by the parasite to form haemozoin pigment. Plasmodium falciparum histidine-rich protein-2 (Pfhrp-2) has been implicated as the catalytic scaffold for detoxification of haem in the malaria parasite. Previously we have shown that a hexapeptide repeat sequence (Ala-His-His-Ala-Ala-Asp), which appears 33 times in Pfhrp-2, may be the major haem binding site in this protein. The haem binding studies carried out by ourselves indicate that up to 18 equivalents of haem could be bound by this protein with an observed K(d) of 0.94 microM. Absorbance spectroscopy provides evidence that chloroquine is capable of extracting haem bound to Pfhrp-2. This was supported by the K(d) value, of 37 nM, observed for the haem-chloroquine complex. The native PAGE studies reveal that the formation of the haem-Pfhrp-2 complex is disrupted by chloroquine. These results indicate that chloroquine may be acting by inhibiting haem detoxification/binding to Pfhrp-2. Moreover, the higher affinity of chloroquine for haem than Pfhrp-2 suggests a possible mechanism of action for chloroquine; it may remove the haem bound to Pfhrp-2 and form a complex that is toxic to the parasite.

[1]  Ashutosh Kumar Singh,et al.  Characterization of Native and Recombinant Falcipain-2, a Principal Trophozoite Cysteine Protease and Essential Hemoglobinase ofPlasmodium falciparum * , 2000, The Journal of Biological Chemistry.

[2]  G. Blauer,et al.  On the preparation of β-haematin , 2000 .

[3]  P. Rangarajan,et al.  Heme metabolism of Plasmodium is a major antimalarial target. , 2000, Biochemical and biophysical research communications.

[4]  T. Egan,et al.  Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of beta-hematin formation, and antiplasmodial activity. , 2000, Journal of medicinal chemistry.

[5]  M. Ignatushchenko,et al.  Xanthones as antimalarial agents: stage specificity. , 2000, The American journal of tropical medicine and hygiene.

[6]  M. Marletta,et al.  Spectroscopic characterization of the heme-binding sites in Plasmodium falciparum histidine-rich protein 2. , 1999, Biochemistry.

[7]  B. K. Park,et al.  New 4-aminoquinoline Mannich base antimalarials. 1. Effect of an alkyl substituent in the 5'-position of the 4'-hydroxyanilino side chain. , 1999, Journal of medicinal chemistry.

[8]  Virander S. Chauhan,et al.  Artemisinin, an Endoperoxide Antimalarial, Disrupts the Hemoglobin Catabolism and Heme Detoxification Systems in Malarial Parasite* , 1999, The Journal of Biological Chemistry.

[9]  H. Ginsburg,et al.  Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. , 1999, Biochemical pharmacology.

[10]  Virander S. Chauhan,et al.  Assay of β-hematin formation by malaria parasite , 1999 .

[11]  P. Loria,et al.  Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. , 1999, The Biochemical journal.

[12]  P B Hedlund,et al.  EasyBound--a user-friendly approach to nonlinear regression analysis of binding data. , 1999, Computer methods and programs in biomedicine.

[13]  Virander S. Chauhan,et al.  HEME POLYMERIZATION BY MALARIAL PARASITE : A POTENTIAL TARGET FOR ANTIMALARIAL DRUG DEVELOPMENT , 1998 .

[14]  M. Foley,et al.  Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.

[15]  Virander S. Chauhan,et al.  Synthetic peptides corresponding to a repetitive sequence of malarial histidine rich protein bind haem and inhibit haemozoin formation in vitro. , 1997, Molecular and biochemical parasitology.

[16]  B. Tekwani,et al.  Formation of haemozoin/β‐haematin under physiological conditions is not spontaneous , 1996, FEBS letters.

[17]  D. Sullivan,et al.  Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins , 1996, Science.

[18]  A. Chou,et al.  Control of heme polymerase by chloroquine and other quinoline derivatives. , 1993, Biochemical and biophysical research communications.

[19]  A. Cerami,et al.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites , 1992, Nature.

[20]  T. Wellems.  How chloroquine works , 1992, Nature.

[21]  A. Chou,et al.  Heme polymerase: modulation by chloroquine treatment of a rodent malaria. , 1992, Life sciences.

[22]  F. Studier,et al.  Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.

[23]  C. Stoscheck,et al.  Quantitation of protein. , 1990, Methods in enzymology.

[24]  T. Wellems,et al.  Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Balasubramanian,et al.  The malaria parasite monitored by photoacoustic spectroscopy. , 1984, Science.

[26]  C. D. Fitch,et al.  Hemin lyses malaria parasites. , 1981, Science.

[27]  A. Chou,et al.  Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. , 1980, Biochemistry.

[28]  P. Thomas,et al.  An improved staining procedure for the detection of the peroxidase activity of cytochrome P-450 on sodium dodecyl sulfate polyacrylamide gels. , 1976, Analytical biochemistry.

[29]  M. Dixon.  The graphical determination of Km and Ki , 1972 .

[30]  D. Warhurst,et al.  Lysosomes, pH and the Anti-malarial Action of Chloroquine , 1972, Nature.

[31]  M. Dixon.  The graphical determination of K m and K i . , 1972, The Biochemical journal.

[32]  H. Sprinz,et al.  Morphological Effects of Chloroquine on Plasmodium berghei in Mice , 1967, Nature.